Evaluation Of The Level Of Satisfaction In Patients With Androgenic Alopecia After Combined Therapy With Minoxidil And Platelet-Rich Plasma
DOI:
https://doi.org/10.56294/saludcyt20251635Keywords:
Androgenic alopecia, platelet-rich plasma, hair growthAbstract
Androgenetic alopecia (AGA) is the most common cause of hair loss in men and women. Conventional treatments include topical or oral minoxidil and oral finasteride, while new options such as laser, microneedling and platelet-rich plasma (PRP) are under study. Combination therapies have been explored to evaluate their synergistic effect, with PRP standing out for its promising results and high acceptance. This descriptive cross-sectional study evaluated the satisfaction of twenty patients (16 women, 4 men) after six sessions of PRP mesotherapy and nocturnal application of minoxidil 5%. A four-item survey on hair growth, reduction of hairless areas, satisfaction and effectiveness was used.
References
1.York K, Meah N, Bhoyrul B, Sinclair R. A review of the treatment of male pattern hair loss. Expert Opinion on Pharmacotherapy [Internet]. 2020;21(5):603–12. Available from: https://pubmed.ncbi.nlm.nih.gov/32066284/ DOI: https://doi.org/10.1080/14656566.2020.1721463
2.Aline Lissa Okita, Steiner D, Sineida Berbert Ferreira, Paulo Müller Ramos, Walter Motta Ferreira, Silveira R, et al. Treatment of Male-Pattern Alopecia with Platelet-Rich Plasma. Skin appendage disorders [Internet]. 2019;6(2):97–101. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32258052/ DOI: https://doi.org/10.1159/000504346
3.Ho CH, Zito PM. Androgenetic Alopecia [Internet]. Nih.gov. StatPearls Publishing; 2019. Available from: https://www.ncbi.nlm.nih.gov/books/NBK430924/
4.Alessandrini A, Bruni F, Piraccini BM, Starace M. Common causes of hair loss – clinical manifestations, trichoscopy and therapy. Journal of the European Academy of Dermatology and Venereology [Internet]. 2021;35(3):629–40. Available from: https://onlinelibrary.wiley.com/doi/10.1111/jdv.17079 DOI: https://doi.org/10.1111/jdv.17079
5. Wei W, Zhang Y, Long, Binman, Zhang Y, Zhang C, Zhang S. Injections of platelet-rich plasma prepared by automatic blood cell separator combined with topical 5% minoxidil in the treatment of male androgenetic alopecia. Skin Res Technol [Internet]. 2023;29(7):e13315. Available from: http://dx.doi.org/10.1111/srt.13315 DOI: https://doi.org/10.1111/srt.13315
6.Suchonwanit P, Thammarucha S, Leerunyakul K. Minoxidil and its use in hair disorders: a review. Drug Design, Development and Therapy [Internet]. 2019 Aug;Volume 13:2777–86. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691938/ DOI: https://doi.org/10.2147/DDDT.S214907
7.Shapiro J, Ho A, Sukhdeo K, Yin L, Lo Sicco K. Evaluation of platelet-rich plasma as a treatment for androgenetic alopecia: A randomized controlled trial. Journal of the American Academy of Dermatology [Internet]. 2020;83(5):1298–303. Available from: https://www.jaad.org/article/S0190-9622(20)32170-8/abstract DOI: https://doi.org/10.1016/j.jaad.2020.07.006
8. Sinclair R. Fortnightly review: Male pattern androgenetic alopecia. BMJ [Internet]. 1998;317(7162):865–9. Available from: http://dx.doi.org/10.1136/bmj.317.7162.865 DOI: https://doi.org/10.1136/bmj.317.7162.865
9. Olsen EA, Messenger AG, Shapiro J, Bergfeld WF, Hordinsky MK, Roberts JL, et al. Evaluation and treatment of male and female pattern hair loss. J Am Acad Dermatol [Internet]. 2005;52(2):301–11. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0190962204010588 DOI: https://doi.org/10.1016/j.jaad.2004.04.008
10. Sinclair RD, Dawber RPR. Androgenetic alopecia in men and women. Clin Dermatol [Internet]. 2001;19(2):167–78. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0738081X00001280 DOI: https://doi.org/10.1016/S0738-081X(00)00128-0
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Paola Stephanie Cáceres Andrade, Dayanara Cecilia Burbano Pijal , Patricio Oswaldo Freire Murgueytio (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
